Investment Summary

The Abraaj Group Invests In Integrated Diagnostics Holdings

On August 1, 2012, asset manager The Abraaj Group invested in healthcare services company Integrated Diagnostics Holdings

Investment Highlights
  • This is The Abraaj Group’s 15th transaction in the Healthcare Services sector.
  • This is The Abraaj Group’s 7th transaction in Egypt.
Investment Fate
  • Integrated Diagnostics Holdings was sold to a consortium of financial buyers in 2014.
  • Integrated Diagnostics Holdings went public in 2015.

Investment Summary

Date 2012-08-01
Target Integrated Diagnostics Holdings
Sector Healthcare Services
Investor(s) The Abraaj Group
Deal Type Stake Purchase

Target

Integrated Diagnostics Holdings

Giza, Egypt
Integrated Diagnostics Holdings is a fully integrated provider of medical diagnostic services with operations in Egypt, Jordan, Nigeria, Sudan, and Saudi Arabia. The group has seven different brands, more than 220 branches, and four central labs across the Middle East. Integrated Diagnostics Holdings is based in Giza, Egypt.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

The Abraaj Group

Dubai, United Arab Emirates

Category Asset Manager
Founded 2002
PE ASSETS 7.4B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Abraaj Capital Limited is a private equity firm that seeks investments in the Middle East, North Africa, and South Asia. Abraaj looks for stable, mature businesses and uses a 'buy and build' strategy for growth. Areas of interest include aerospace, healthcare, transportation, financial services, leisure, education, energy, and manufacturing. In addition to its buyout and growth capital investments, Abraaj also invests in real estate and infrastructure. Abraaj Capital was formed in 2002 and is based in Dubai.


DEAL STATS #
Overall 138 of 182
Sector: Healthcare Services M&A 15 of 24
Type: Stake Purchase M&A Deals 3 of 6
Country: Egypt M&A 7 of 9
Year: 2012 M&A 17 of 21
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-07-19 IFaB

Col. Arenal Tepepan, Mexico

IFaB is the Mexican leader in designing and performing human studies, which are required for medical drugs to receive legal certification. IFaB is a contract research organization that carries out bioavailability and bioequivalency studies requested by pharmaceutical companies. The company has been certified by the Mexican and Brazilian sanitary authorities (COFEPRIS and ANVISA respectively). IFaB is the only non-Brazilian company in the Americas that has the ANVISA certification.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-11-01 Moulin d’Or

Tunisia

Moulin d’Or is a leading baked goods company in Tunisia with a 41% market share. In 2012, Tunisians consumed more than 175 million single-serving cakes made by the company. Moulin d’Or is acclaimed by Tunisian consumers for its fresh and tasty cakes, good quality ingredients, generous servings and affordable prices that make it accessible to consumers from all income brackets. Moulin d’Or’s products are also highly praised in Algeria and Libya where the company has a significant presence.

Buy -